Join
Live feed
·
NEWSReleasevia Quantisnow
Eliem Therapeutics Inc logo

Eliem Therapeutics Files Prospectus Relates To Resale From Time To Time Of Up To 36.8M Shares Of Common Stock By Selling Stockholders

ByQuantisnow·Wall Street's wire, on your screen.
ELYM· Eliem Therapeutics Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ELYM (Eliem Therapeutics Inc) and more on Quantisnow.